Shortened Course Adjuvant Radiotherapy Following TORS
Clinical trial NCT05714657 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05714657
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2026-10-10
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.